Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49,261 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Visit Adherence of Mild to Moderate Psoriasis Patients: A Mobile-Based Randomized Study.
Zhao Y, Wang G, Ni W, Song Z, Chen K, Zhang C, Zhang S, Ding Y, Zheng M, Shi Y, Lin Z, Liu X, Zhang X, Zhou Q, Ahmed KD. Zhao Y, et al. Among authors: wang g. Patient Prefer Adherence. 2021 Jan 5;14:2551-2557. doi: 10.2147/PPA.S277103. eCollection 2020. Patient Prefer Adherence. 2021. PMID: 33447016 Free PMC article.
Calcipotriol plus betamethasone dipropionate gel compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized, controlled trial investigating efficacy and safety in a Chinese population.
Ma L, Yang Q, Yang H, Wang G, Zheng M, Hao F, Gu J, Sun Q, Cui P, Ge M, Li R, Gao T, Facy P, Kurvits M, Xu Z, Xu J. Ma L, et al. Among authors: wang g. Int J Dermatol. 2016 Jan;55(1):106-13. doi: 10.1111/ijd.12788. Epub 2015 Jun 20. Int J Dermatol. 2016. PMID: 26094549 Clinical Trial.
The efficacy and safety of tofacitinib in Asian patients with moderate to severe chronic plaque psoriasis: A Phase 3, randomized, double-blind, placebo-controlled study.
Zhang J, Tsai TF, Lee MG, Zheng M, Wang G, Jin H, Gu J, Li R, Liu Q, Chen J, Tu C, Qi C, Zhu H, Ports WC, Crook T. Zhang J, et al. Among authors: wang g. J Dermatol Sci. 2017 Oct;88(1):36-45. doi: 10.1016/j.jdermsci.2017.05.004. Epub 2017 May 16. J Dermatol Sci. 2017. PMID: 28558978 Free article. Clinical Trial.
Etanercept biosimilar (recombinant human tumor necrosis factor-α receptor II: IgG Fc fusion protein) and methotrexate combination therapy in Chinese patients with moderate-to-severe plaque psoriasis: a multicentre, randomized, double-blind, placebo-controlled trial.
Liu LF, Chen JS, Gu J, Xu JH, Jin HZ, Pang XW, Wang G, Yu C, Song ZQ, Guo ZP, Li W, Lai W, Cui PG, Chen M, Fang H, Lyu CZ, Li YZ, Sun Q, Xie HF, Liu XM, Gao XH, Shi YL, Zhao NQ, Zhang W, Zheng M. Liu LF, et al. Among authors: wang g. Arch Dermatol Res. 2020 Aug;312(6):437-445. doi: 10.1007/s00403-019-02024-6. Epub 2019 Dec 23. Arch Dermatol Res. 2020. PMID: 31873772 Clinical Trial.
Expert consensus on the use of omalizumab in chronic urticaria in China.
Zhao Z, Cai T, Chen H, Chen L, Chen Y, Gao X, Gao X, Geng S, Guo Y, Hao F, Hao G, Hu Y, Jin H, Jin Z, Li C, Li H, Li J, Li Y, Liang Y, Liu G, Liu Q, Long H, Ma L, Shang Y, Song Y, Song Z, Su X, Sui H, Sun Q, Sun Y, Tang J, Tong X, Wang H, Wang G, Wang L, Wang S, Xiang L, Xiao T, Xie Z, Ye L, Yu Y, Zhang C, Zhang L, Zhang S, Zheng R, Zhi L, Zhou W, Zou Y, Maurer M. Zhao Z, et al. Among authors: wang h, wang g, wang l, wang s. World Allergy Organ J. 2021 Dec 5;14(11):100610. doi: 10.1016/j.waojou.2021.100610. eCollection 2021 Nov. World Allergy Organ J. 2021. PMID: 34934470 Free PMC article. Review.
A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasis.
Yu C, Zhang F, Ding Y, Li Y, Zhao Y, Gu J, Guo S, Pan W, Jin H, Sun Q, Kang X, Yang Q, Jiang X, Song Z, Lu Q, Pang X, Kuang Y, Deng D, Li Y, Zhang C, Tao J, Xie L, Wang Y, Wang J, Wang G. Yu C, et al. Among authors: wang g, wang j, wang y. Int Immunopharmacol. 2022 Nov;112:109248. doi: 10.1016/j.intimp.2022.109248. Epub 2022 Sep 18. Int Immunopharmacol. 2022. PMID: 36126411 Clinical Trial.
Treatment of psoriasis with recombinant human LFA3-antibody fusion protein: a multi-center, randomized, double-blind trial in a Chinese population.
Yan H, Tang M, You Y, Yu JB, Zhang JA, Li XH, Sun JF, Jiang YQ, Chen H, Guo ZP, Xiong L, He W, Li Z, Gu J, Gao CF, Guo ZL, Gao TW, Wang G, Li XP, Li J, Hao F, Guo YJ. Yan H, et al. Among authors: wang g. Eur J Dermatol. 2011 Sep-Oct;21(5):737-43. doi: 10.1684/ejd.2011.1465. Eur J Dermatol. 2011. PMID: 21737373 Clinical Trial.
49,261 results
You have reached the last available page of results. Please see the User Guide for more information.